Expand REPL Menu
REPL MENU

REPL Latest Press Releases

-- March 2, 2026 --

Biliary Tract Cancer Market is Predicted to Exhibit Remarkable Growth at a CAGR of 10.1% During the Forecast Period (2025-2034) | DelveInsight PRNewswire 5:31 PM
Replimune to Present at Two Upcoming Investor Conferences Globe Newswire 8:00 AM

-- February 5, 2026 --

Johnson Fistel, PLLP Begins Investigation on Behalf of Long-Term Shareholders of Replimune Group, Inc. (REPL), Sable Offshore Corp. (SOC), Sarepta Therapeutics, Inc. (SRPT), and Semler Scientific, Inc. (SMLR) Globe Newswire 10:47 AM

-- February 3, 2026 --

Replimune Reports Fiscal Third Quarter 2026 Financial Results and Provides Corporate Update Globe Newswire 8:00 AM

-- January 20, 2026 --

Johnson Fistel, PLLP Investigates Claims on Behalf of Long-Term Shareholders of Alto Neuroscience, Inc. (ANRO), Atkore Inc. (ATKR), Replimune Group, Inc. (REPL), and Fly-E Group, Inc. (FLYE) Globe Newswire 9:31 AM

-- December 18, 2025 --

Replimune to Present at the 44th Annual J.P. Morgan Healthcare Conference Globe Newswire 8:00 AM

-- November 7, 2025 --

Replimune Presents Late-Breaking Abstract and Additional Posters on RP1 at 40th Annual Meeting of the Society for the Immunotherapy of Cancer (SITC 2025) Globe Newswire 4:45 PM

-- November 6, 2025 --

Replimune Reports Fiscal Second Quarter 2026 Financial Results and Provides Corporate Update Globe Newswire 8:00 AM

-- October 20, 2025 --

Replimune Announces FDA Acceptance of BLA Resubmission of RP1 for the Treatment of Advanced Melanoma Globe Newswire 7:00 AM

-- October 19, 2025 --

Replimune Highlights Acral Melanoma Data for RP1 plus Nivolumab at the ESMO Congress 2025 Globe Newswire 8:00 AM
Market Data Delayed 15 Minutes